NXC-201 is the only CAR-T therapy currently in development in AL Amyloidosis, mentioned in a review article entitled “Systemic Light Chain Amyloidosis” published in June, 2024 New England Journal of ...
As part of the global effort to harness power from fusing plasma, scientists worked on the computer codes, engineering and physics for a new and unique fusion reactor: the SMall Aspect Ratio Tokamak.
Like atoms coming together to release their power, fusion researchers worldwide are joining forces to solve the world's energy crisis. Harnessing the power of fusing plasma as a reliable energy source ...
The University of Pittsburgh Schools of the Health Sciences has been awarded approximately $100 million from the U.S. Department of Defense (DOD) to continue a clinical research program that is ...